Journal
EYE
Volume 24, Issue 4, Pages 717-719Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/eye.2009.94
Keywords
bevacizumab; silicone oil; vitrectomy; neovascular glaucoma; diabetic retinopathy
Categories
Ask authors/readers for more resources
Purpose To evaluate the effect of intra-silicone injection of bevacizumab for the treatment of neovascular glaucoma (NVG) after vitrectomy for advanced proliferative diabetic retinopathy. Methods Bevacizumab was injected into the silicone oil in five pseudophakic eyes of five patients with NVG. The iris neovascularization (INV) and NVG had developed 1.5-4 months after vitrectomy and silicone oil tamponade. The main outcome measures were regression of INV, intraocular pressure and visual acuity. Results In all eyes, INV regressed and intraocular pressure was controlled within 7 days. Visual acuity improved in all eyes. In one patient, INV and NVG recurred 10 weeks after the injection and was successfully treated with a repeat intra-silicone bevacizumab injection. Conclusion Intra-silicone injection of bevacizumab is effective in the treatment of patients with INV and NVG after vitrectomy for advanced proliferative diabetic retinopathy. Eye (2010) 24, 717-719; doi: 10.1038/eye.2009.94; published online 1 May 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available